Are there additional options for the treatment of refractory obstetric antiphospholipid syndrome?

Lupus

Volumn 22, Issue 7, 2013, Pages 754-755

  Gomez Puerta J A ^a   Cervera, R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIPHOSPHOLIPID SYNDROME; HUMAN; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; REFRACTORY OBSTETRIC ANTIPHOSPHOLIPID SYNDROME; TREATMENT PLANNING;

ANTIPHOSPHOLIPID SYNDROME; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84879208838     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313490433     Document Type: Letter

References (10)

1. Alijotas-Reig J. Treatment of refractory obstetric antiphospholipid syndrome: The state of the art and new trends in the therapeutic management. Lupus. 2013 ; 22: 6-17
2. Bontadi A, Ruffatti A, Marson P, et al. Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J Clin Apher. 2012 ; 27: 200-204
3. Gómez-Puerta JA, Cervera R, Espinosa G, et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: Maternal and fetal characteristics of 15 cases. Ann Rheum Dis. 2007 ; 66: 740-746
4. Deeks ED. Certolizumab pegol: A review of its use in the management of rheumatoid arthritis. Drugs. 2013 ; 73: 75-97
5. Mahadevan U, Wolf DC, Dubinsky M, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 ; 11: 286-292
6. Schnitzler F, Fidder H, Ferrante M, et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis. 2011 ; 17: 1846-1854
7. Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL. Anti-TNF therapies and pregnancy: Outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011 ; 70: 823-826
8. Pons-Estel GJ, Salerni GE, Serrano RM, et al. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature. Autoimmun Rev. 2011 ; 10: 679-684
9. Gómez-Puerta J, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: Diagnosis and management in pregnancy. Clin Lab Med. :
10. El-Haieg DO, Zanati MF, El-Foual FM. Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome. Int J Gynaecol Obstet. 2007 ; 99: 236-241